Recombination of host cell mRNA with the Asia 1 foot-and-mouth disease virus genome in cell suspension culture
Foot-and-mouth disease virus (FMDV) exhibits high mutation rates during replication. In this study, an isolate of FMDV serotype Asia-1 was serially passaged in a BHK-21 cell monolayer and then adapted to serum-free BHK-21 cell suspension culture to produce a seed virus for production of an inactivated vaccine. Analysis of the sequence encoding the structural proteins of the virus at various passages showed the presence of overlapping peaks in sequencing electropherograms after nucleotide 619 of VP1 in viruses recovered from the fourth passage in suspension culture, suggesting the possible introduction of an insertion or deletion into this portion of the viral genome of our seed virus stock. To evaluate this phenomenon, a virus designated “Vac-Asia1-VDLV”, was isolated by plaque purification from the tenth passage in suspension culture. Sequencing results showed that a 12-nt-long exogenous sequence was inserted into the 3’ end of the VP1 coding region at the position where the original overlapping peaks were identified. Analysis of the host cell transcriptome showed that the 12-nt sequence was identical to a highly expressed sequence in BHK-21 cells, strongly suggesting that recombination between the FMDV genome and host cell mRNA produced the recombinant virus. A growth curve showed that the virus with the 12-nt insertion reached a peak earlier than the parental strain and that this virus had acquired the ability to bind to the cell surface by a mechanism that was not dependent on integrin or the heparan sulfate receptor. This novel pathogen-host cell recombination event is discussed in terms of the mechanism of viral RNA replication and the phenotypic constraints of FMDV biology and evolution.
We sincerely thank all the technical staffs of Tecon Co., LTD and China Animal Husbandry Industry Co., LTD for their help in these studies. We thank Yingju Xia of the Department of Reference Material at China Institute of Veterinary Drug Control for critical reading of the manuscript.
This study was funded by National Key Research and Development Program of China (No. 2016YFD0501500) and the Special Fund for Agro-Scientific Research in the Public Interest (201303046).
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 4.Zhang Q, Li D, Liu X, Liu Z, Cai X, Wu G, Qi S, Yang S, Yan X, Shang Y, He J, Ma J, Li J, Ma W, Han R, Liu X, Zhang J, Xie Q, Zhang Z (2008) Experimental studies with foot-and-mouth disease virus type Asia-1, responsible for the 2005 epidemic in China. Res Vet Sci 85:368–371CrossRefPubMedGoogle Scholar
- 6.Saraiva V (2003) Vaccines and foot-and-mouth disease eradication in South America. Dev Biol (Basel) 114:67–77Google Scholar
- 7.Malirat V, de Barros JJ, Bergmann IE, Campos Rde M, Neitzert E, da Costa EV, da Silva EE, Falczuk AJ, Pinheiro DS, de Vergara N, Cirvera JL, Maradei E, Di Landro R (2007) Phylogenetic analysis of foot-and-mouth disease virus type O re-emerging in free areas of South America. Virus Res 124:22–28CrossRefPubMedGoogle Scholar
- 11.Bai X, Bao H, Li P, Wei W, Zhang M, Sun P, Cao Y, Lu Z, Fu Y, Xie B, Chen Y, Li D, Luo J, Liu Z (2014) Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor. Virol J 11:132CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Reeve R, Blignaut B, Esterhuysen JJ, Opperman P, Matthews L, Fry EE, de Beer TA, Theron J, Rieder E, Vosloo W, O’Neill HG, Haydon DT, Maree FF (2010) Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus. PLoS Comput Biol 6:e1001027CrossRefPubMedPubMedCentralGoogle Scholar
- 20.OIE (2015) Foot and mouth disease, Chap 215. In: OIE (ed) Manual of diagnostic tests and vaccines for terrestrial animals, 2012 ed. OIE, ParisGoogle Scholar
- 32.Rai DK, Segundo FD, Schafer E, Burrage TG, Rodriguez LL, de Los Santos T, Hoeprich PD, Rieder E (2016) Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity. Virology 495:136–147CrossRefPubMedGoogle Scholar
- 35.Podnar J, Deiderick H, Huerta G, Hunicke-Smith S (2014) Next-generation sequencing RNA-seq library construction. Curr Protoc Mollar Biol/edited by Frederick M. Ausubel [et al.] 106:421–419Google Scholar
- 37.Haas BJ, Papanicolaou A, Yassour M, Grabherr M, Blood PD, Bowden J, Couger MB, Eccles D, Li B, Lieber M, Macmanes MD, Ott M, Orvis J, Pochet N, Strozzi F, Weeks N, Westerman R, William T, Dewey CN, Henschel R, Leduc RD, Friedman N, Regev A (2013) De novo transcript sequence reconstruction from RNA-Seq: reference generation and analysis with trinity. Natprotocols 8:1494–1512Google Scholar
- 39.Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28:511–515CrossRefPubMedPubMedCentralGoogle Scholar